Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization
Ying‐Hsia Chu(Harvard University), Peter M. Sadow(Massachusetts Eye and Ear Infirmary), Lori J. Wirth(Massachusetts General Hospital), Dora Dias‐Santagata(Harvard University), William C. Faquin(Massachusetts General Hospital), Vânia Nosé(Massachusetts General Hospital), Alexander Farahani(Harvard University)
Cited by 121
Related Papers
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
|Cell|2017|2.6k
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
|Cancer Cell|2010|1.1k
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
|Journal of Clinical Oncology|2017|653